Conquering Diseases

Cancer Therapy Risk-Reduction With Intensive Systolic Blood Pressure Management

Description

Seeking men and women 18 years of age or older, with kidney or thyroid cancer who are taking medications that help stop the spread of these cancers to look at the effects of blood pressure and blood pressure monitoring related to these medications.

Overview

We are studying the relationship between certain medicines used to help stop certain types of cancers from growing and blood pressure. This type of medicine is known as an anti-angiogenic tyrosine kinase inhibitor (AA-TKI). These medicines can also affect the blood pressure. This study will explore the effects of blood pressure targets in patients receiving AA-TKIs.

What we're hoping for

The goal is to answer the following question: can lowering systolic blood pressure to less than 120mmHg be achieved, well tolerated and beneficial as compared to less than 140mmHg?

Additional Information

ClinicalTrials.gov Identifier: NCT04467021

 Principal Investigator

Kriti  Mittal, MD, MS

UMass Memorial Health Care

 Study Contact

The Cancer  Research Office

508-856-3216

Cancer.research@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989